Karyopharm Therapeutics (KPTI) Interest Expenses (2019 - 2026)
Karyopharm Therapeutics (KPTI) posted Interest Expenses of $13.14 million for Q2 2026, up 17.1% from $11.23 million a year earlier.
Powered by 
Analysis
Karyopharm Therapeutics (KPTI) Interest Expenses (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest Expenses at Karyopharm Therapeutics was $48 million, up 7.1% year-over-year; for FY2025, it was $45.85 million, up 22.5% from FY2024.
- Annual Interest Expenses shows a five-year compound annual growth rate of 11.1% (FY2020 to FY2025).
- In prior years, Karyopharm Therapeutics' Interest Expenses was $37.42 million in FY2024 (+57.1%), $23.82 million in FY2023 (-4.7%), $25 million in FY2022 (-4.0%) and $26.05 million in FY2021 (-4.0%).
- The Q2 2026 figure stands as the highest quarterly Interest Expenses in data going back to Q1 2019.
- On a year-over-year basis, Interest Expenses increased in six of the last seven quarters, with growth averaging 43.8%.
- The strongest year-over-year quarter for Interest Expenses in the past five years was Q3 2024, with growth of 87.5%; the weakest was Q4 2022, with a decline of 25.9%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Karyopharm Therapeutics | 35.30 Mn | -191.12 Mn | 32.35 Mn | 13.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.14 Mn |
| Dec 31, 2025 | 12.62 Mn |
| Sep 30, 2025 | 11.01 Mn |
| Jun 30, 2025 | 11.23 Mn |
| Mar 31, 2025 | 10.99 Mn |
| Dec 31, 2024 | 11.20 Mn |
| Sep 30, 2024 | 11.39 Mn |
| Jun 30, 2024 | 8.95 Mn |
| Mar 31, 2024 | 5.88 Mn |
| Dec 31, 2023 | 6.21 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 5.78 Mn |
| Mar 31, 2023 | 5.76 Mn |
| Dec 31, 2022 | 5.89 Mn |
| Sep 30, 2022 | 6.11 Mn |
| Jun 30, 2022 | 6.31 Mn |
| Mar 31, 2022 | 6.68 Mn |
| Dec 31, 2021 | 7.94 Mn |
| Sep 30, 2021 | 8.01 Mn |
| Jun 30, 2021 | 5.00 Mn |
API Access
Karyopharm Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "KPTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=KPTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();